These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 25040510)

  • 1. Maternal and fetal zidovudine pharmacokinetics during pregnancy and labour: too high dose infused at labour?
    Fauchet F; Treluyer JM; Valade E; Benaboud S; Pannier E; Firtion G; Foissac F; Bouazza N; Urien S; Hirt D
    Br J Clin Pharmacol; 2014 Dec; 78(6):1387-96. PubMed ID: 25040510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of oral zidovudine administered during labour: a preliminary study.
    Mirochnick M; Rodman JH; Robbins BL; Fridland A; Gandía J; Hitti J; Bardeguez A; Rathore MH; Gonzalez Garcia A; Cababasay M; Samson P; Mofenson L; Bryson YJ; Dorenbaum A
    HIV Med; 2007 Oct; 8(7):451-6. PubMed ID: 17760737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
    Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Volmink J; Siegfried NL; van der Merwe L; Brocklehurst P
    Cochrane Database Syst Rev; 2007 Jan; (1):CD003510. PubMed ID: 17253490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral zidovudine during labor to prevent perinatal HIV transmission, Bangkok: tolerance and zidovudine concentration in cord blood. Bangkok Collaborative Perinatal HIV Transmission Study Group.
    Bhadrakom C; Simonds RJ; Mei JV; Asavapiriyanont S; Sangtaweesin V; Vanprapar N; Moore KH; Young NL; Hannon WH; Mastro TD; Shaffer N
    AIDS; 2000 Mar; 14(5):509-16. PubMed ID: 10780713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications of the kinetics of zidovudine in the pregnant baboon following oral administration.
    Garland M; Szeto HH; Daniel SS; Tropper PJ; Myers MM; Stark RI
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec; 19(5):433-40. PubMed ID: 9859956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short course zidovudine maternal treatment in HIV-1 vertical transmission: randomized controlled multicenter trial.
    Limpongsanurak S; Thaithumyanon P; Chaithongwongwatthana S; Thisyakorn U; Ruxrungtham K; Kongsin P; Tarounotai U; Chantheptaewan N; Triratwerapong T; Ubolyam S; Phanuphak P; Virutamasen P; Hanwanich M; Hawanon P; Chulasugondha P
    J Med Assoc Thai; 2001 Jun; 84 Suppl 1():S338-45. PubMed ID: 11529355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High exposure to zidovudine during the first 2 weeks of life and concentration-toxicity relationships.
    Hirt D; Warszawski J; Firtion G; Giraud C; Chappuy H; Lechenadec J; Benaboud S; Urien S; Blanche S; Tréluyer JM
    J Acquir Immune Defic Syndr; 2013 Aug; 63(5):555-62. PubMed ID: 23481669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal and umbilical cord serum zidovudine levels in human immunodeficiency virus infection.
    Phuapradit W; Sirinavin S; Taneepanichskul S; Chaovavanich A; Wiratchai A; Sunthornkachit R; Puchaiwatanon O
    Aust N Z J Obstet Gynaecol; 1998 Aug; 38(3):288-92. PubMed ID: 9761155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrapartum zidovudine infusion alone failed to reduce both maternal HIV-1 viral load and HIV-1 infection in infant.
    Limpongsanurak S; Thaithumyanon P; Thisyakorn U; Ruxrungtham K; Chaithongwongwatthana S; Kongsin P; Tarounotai U; Chantheptaewan N; Triratwerapong T; Ubolyam S; Phanuphak P
    J Med Assoc Thai; 2001 May; 84(5):611-6. PubMed ID: 11560207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV infection and zidovudine use in childbearing women.
    Sia J; Paul S; Martin RM; Cross H
    Pediatrics; 2004 Dec; 114(6):e707-12. PubMed ID: 15545619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is intrapartum intravenous zidovudine for prevention of mother-to-child HIV-1 transmission still useful in the combination antiretroviral therapy era?
    Briand N; Warszawski J; Mandelbrot L; Dollfus C; Pannier E; Cravello L; Nguyen R; Matheron I; Winer N; Tubiana R; Rouzioux C; Faye A; Blanche S;
    Clin Infect Dis; 2013 Sep; 57(6):903-14. PubMed ID: 23728147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetics study of recommended zidovudine doses in HIV-1-infected children.
    Fauchet F; Treluyer JM; Frange P; Urien S; Foissac F; Bouazza N; Benaboud S; Blanche S; Hirt D
    Antimicrob Agents Chemother; 2013 Oct; 57(10):4801-8. PubMed ID: 23877688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of zidovudine treatment in late pregnancy on HIV-1 in utero transmission.
    Taneepanichskul S; Sirinavin S; Phuapradit W; Chaturachinda K
    Aust N Z J Obstet Gynaecol; 1997 Aug; 37(3):329-31. PubMed ID: 9325519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of didanosine and drug resistance mutations in infants exposed to zidovudine during gestation or postnatally and treated with didanosine or zidovudine in the first three months of life.
    Kovacs A; Cowles MK; Britto P; Capparelli E; Fowler MG; Moye J; McIntosh K; Rathore MH; Pitt J; Husson RN
    Pediatr Infect Dis J; 2005 Jun; 24(6):503-9. PubMed ID: 15933559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1.
    Moodley D; Moodley J; Coovadia H; Gray G; McIntyre J; Hofmyer J; Nikodem C; Hall D; Gigliotti M; Robinson P; Boshoff L; Sullivan JL;
    J Infect Dis; 2003 Mar; 187(5):725-35. PubMed ID: 12599045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nevirapine and zidovudine at birth to reduce perinatal transmission of HIV in an African setting: a randomized controlled trial.
    Taha TE; Kumwenda NI; Hoover DR; Fiscus SA; Kafulafula G; Nkhoma C; Nour S; Chen S; Liomba G; Miotti PG; Broadhead RL
    JAMA; 2004 Jul; 292(2):202-9. PubMed ID: 15249569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrapartum use of zidovudine in a large cohort of pregnant women living with HIV in Italy.
    Taramasso L; Bovis F; Di Biagio A; Mignone F; Giaquinto C; Tagliabue C; Giacomet V; Genovese O; Chiappini E; Salomè S; Badolato R; Carloni I; Cellini M; Dodi I; Bossi G; Allodi A; Bernardi S; Consolini R; Dedoni M; Banderali G; Mazza A; Pruccoli G; Rampon O; Erba P; Di Pietro G; Montagnani C; Capasso L; Dotta L; Zallocco F; De Martino M; Lisi C; Tovo PA; Bassetti M; Gabiano C; Galli L;
    J Infect; 2022 Nov; 85(5):565-572. PubMed ID: 35987392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zidovudine.
    Sperling R
    Infect Dis Obstet Gynecol; 1998; 6(5):197-203. PubMed ID: 9894173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Field efficacy of zidovudine, lamivudine and single-dose nevirapine to prevent peripartum HIV transmission.
    Dabis F; Bequet L; Ekouevi DK; Viho I; Rouet F; Horo A; Sakarovitch C; Becquet R; Fassinou P; Dequae-Merchadou L; Welffens-Ekra C; Rouzioux C; Leroy V;
    AIDS; 2005 Feb; 19(3):309-18. PubMed ID: 15718842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.